My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 840

    1.

    Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

    Hart RG, Pearce LA, Aguilar MI.

    Ann Intern Med. 2007 Jun 19;146(12):857-67.PMID: 17577005 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

    Hart RG, Benavente O, McBride R, Pearce LA.

    Ann Intern Med. 1999 Oct 5;131(7):492-501.PMID: 10507957 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

    Aguilar MI, Hart R.

    Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001927. Review.PMID: 16034869 [PubMed - indexed for MEDLINE]Related articles

    4.

    Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.

    Aguilar MI, Hart R, Pearce LA.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006186. Review.PMID: 17636831 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

    [No authors listed]

    Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254. PMID: 8018000 [PubMed - indexed for MEDLINE]Related articles

    6.

    Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

    Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

    Cochrane Database Syst Rev. 2001;(1):CD001938. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001938. PMID: 11279741 [PubMed - indexed for MEDLINE]Related articles

    7.

    WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

    Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001938. Review.PMID: 17636690 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

    Benavente O, Hart R, Koudstaal P, Laupacis A, McBride R.

    Cochrane Database Syst Rev. 2000;(2):CD001927. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD001927. PMID: 10796453 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.

    Algra A, de Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.

    Cochrane Database Syst Rev. 2001;(4):CD001342. Review. Update in: Cochrane Database Syst Rev. 2006;3:CD001342. PMID: 11687110 [PubMed - indexed for MEDLINE]Related articles

    10.

    Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.

    Saxena R, Koudstaal P.

    Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000187. Review.PMID: 15494992 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

    Benavente O, Hart R, Koudstaal P, Laupacis A, McBride R.

    Cochrane Database Syst Rev. 2000;(2):CD001925. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD001925. PMID: 10796452 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

    JAMA. 2003 Nov 26;290(20):2685-92.PMID: 14645310 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.

    Gage BF, Cardinalli AB, Owens DK.

    Stroke. 1998 Jun;29(6):1083-91.PMID: 9626276 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

    Aguilar M, Hart R.

    Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001925. Review.PMID: 16235290 [PubMed - indexed for MEDLINE]Related articles

    15.

    Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

    van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B.

    JAMA. 2002 Nov 20;288(19):2441-8.PMID: 12435257 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Guidelines for stroke prevention in patients with atrial fibrillation.

    Howard PA.

    Drugs. 1999 Dec;58(6):997-1009. Review.PMID: 10651387 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.

    Gulløv AL, Koefoed BG, Petersen P.

    Arch Intern Med. 1999 Jun 28;159(12):1322-8.PMID: 10386508 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

    Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A; SPORTIF Executive Steering Committee for the SPORTIF V Investigators.

    JAMA. 2005 Feb 9;293(6):690-8.PMID: 15701910 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.

    Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E.

    Cerebrovasc Dis. 2000 Jan-Feb;10(1):39-43.PMID: 10629345 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.

    Perret-Guillaume C, Wahl DG.

    Thromb Haemost. 2004 Feb;91(2):394-402.PMID: 14961170 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity